Revival of physostigmine: a randomized, double-blind, placebo-controlled clinical trial and pharmacokinetic/pharmacodynamic study on the adjunctive use of physostigmine salicylate (Anticholium®) in perioperative septic shock

Ähnliche Einträge

• Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se)
  von: Zimmermann, Johannes B., et al.
  Veröffentlicht: (2017)
• Revival of physostigmine: a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients
  von: Pinder, Nadine, et al.
  Veröffentlicht: (2015)
• Continuous infusion of physostigmine in patients with perioperative septic shock: a pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling
  von: Pinder, Nadine, et al.
  Veröffentlicht: (2019)
• Effect of physostigmine on recovery from septic shock following intra-abdominal infection - Results from a randomized, double-blind, placebo-controlled, monocentric pilot trial (Anticholium® per Se)
  von: Pinder, Nadine, et al.
  Veröffentlicht: (2019)
• Neuroinflammation und Physostigmin: psychometrische Untersuchungen an Ratten nach Leberteilresektion
  von: Rullof, Rebecca
  Veröffentlicht: (2018)